GlycoSeLect Ltd Featured in the Irish Times

GlycoSeLect Ltd was recently featured in an Irish Times article about new innovators.

“At first glance, glycoproteins may not seem to have much relevance for everyday life, but they are in fact the bedrock of the biopharmaceutical industry and are used in the food and cosmetics sectors.

The problem with glycoproteins is that they are difficult to analyse, so anything that simplifies the process is of big interest to the multimillion dollar turnover industries involved.

Currently making waves in the glycoproteins pool is Dublin City University life-sciences spin-out GlycoSeLect. Set up in 2013, its disruptive technology can make glycoprotein analysis and manufacturing cheaper and more effective.”

About GlycoSelect Ltd

GlycoSeLect Ltd is an early-stage biotechnology company developing proprietary innovative and cost-efficient solutions for the analysis, characterisation and purification of pharmaceutical products. Spun-out from Dublin City University in 2013, GlycoSeLect specialises in the development of RPLs; proteins that enable the more efficient detection, analysis and selective isolation of glycosylated biomolecules. GlycoSeLect established a UK based subsidiary in 2015 to support further development, provide wider geographic reach and drive commercialisation.

More Stories